tiprankstipranks
Neurogene (NGNE)
NASDAQ:NGNE
US Market

Neurogene (NGNE) Financial Statements

430 Followers

Neurogene Financial Overview

Neurogene's market cap is currently ―. The company's EPS TTM is $-2.654; its P/E ratio is -16.04; Neurogene is scheduled to report earnings on May 10, 2024, and the estimated EPS forecast is $-1.03. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -16.92M$ -28.89M$ -3.48M$ -3.07M$ -15.13M
EBITDA$ -16.55M$ -25.15M$ -2.44M-$ -15.05M
Net Income Common Stockholders$ -16.92M$ -15.50M$ -4.53M$ -2.08M$ -14.20M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 169.53M$ 197.16M$ 78.51M$ 82.06M$ 83.44M
Total Assets$ 195.35M$ 222.57M$ 89.59M$ 94.00M$ 98.46M
Total Debt$ 14.41M$ 14.97M$ 10.69M$ 11.04M$ 11.68M
Net Debt$ -155.13M$ -182.19M$ -67.81M$ -71.02M$ -71.75M
Total Liabilities$ 24.57M$ 36.55M$ 14.35M$ 14.43M$ 17.10M
Stockholders Equity$ 170.78M$ 186.02M$ 75.23M$ 79.58M$ 81.36M
Cash Flow-
Free Cash Flow$ -21.77M$ -31.93M$ -4.27M-$ -13.47M
Operating Cash Flow$ -21.70M$ -30.05M$ -4.27M$ -4.05M$ -13.05M
Investing Cash Flow$ 29.93M$ 16.96M$ -1.61M$ -411.00K$ 10.71M
Financing Cash Flow$ -6.52M$ 92.84M$ -1.00K$ -294.00K$ -66.00K
Currency in USD

Neurogene Earnings and Revenue History

Neurogene Debt to Assets

Neurogene Cash Flow

Neurogene Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis